Mediprobe Research Inc. conducts Phase II-IV dermatological clinical research trials. Acclaim Pharma Research Inc., its sister company conducts Phase I studies.
Mediprobe Research Inc. has the in-house capability and expertise to take your Phase II-IV clinical trial right from development through to statistical analysis and final report writing.
Acclaim Pharma Research. is a contract research organization (CRO) that specializes in the management of Phase I Trials. Our 90-bed facility will allow us to comfortably house subjects for extended time periods while we conduct first-in-human studies and pharmacokinetic studies, such as those needed to show bioequivalence between a generic product and the innovative drug. Acclaim Pharma Research has partnerships with state-of-the-art research and analytical laboratories, which adds an additional level of support to our impressive clinical trials capabilities. For more information on Acclaim Pharma Research, visit us at www.acclaimpharma.com.
- We can design your study, write the protocol, and develop the case report and informed consent forms.
- Our experienced staff and dedication to detail ensure that IRB, (REB), TPD, FDA and other regulatory approvals are obtained with a minimum of delay.
- Our experienced data management group routinely organizes and processes data in the preparation of manuscripts and other medical literature.
- We will conduct your Phase II-IV Clinical Trial in accordance with Good Clinical Practices, as set out by the ICH. We ensure that your trial will meet all applicable regulatory requirements.
Mediprobe Research is located in London Ontario, Canada, just south east of Toronto with easy driving access from the London International Airport as well as highways 401 and 402.